Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06233578 · ClinicalTrials.gov registry record · NA
ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT06233578: Completed NA study, sponsored by NYU Langone Health.
NCT06233578 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06233578, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the impact of the RADPAD in proximal operators in a contemporary cardiac catheterization laboratory (CCL), during diagnostic, coronary and structural cardiac catheterization procedures, in a large prospective, randomized controlled trial. Up to 1,000 patient-cases and up to 100 proximal operator-subjects expected to be enrolled across 1 site. The proximal operator cohort is expected to include a few interventional cardiologist attending physicians, interventional cardiology fellows, cardiovascular disease fellows and physician assistants performing multiple cases each, which in total would amount to 1,000 cases performed by 100 proximal operators. The primary outcome of interest was relative exposure of the proximal operator between the guideline directed radiation protocols and RADPAD use vs. guideline directed radiation protocols alone.
Primary Outcome
This is a continuous variable which will be analyzed statistically using the student's t-test.
Interventions
- DEVICE RADPAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT06233578 record still lists
NCT06233578 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 1 intervention - of which RADPAD is the first listed.
NCT06233578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06233578 about?
NCT06233578 is a clinical study titled "ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial". The purpose of this study is to examine the impact of the RADPAD in proximal operators in a contemporary cardiac catheterization laboratory (CCL), during diagnostic, coronary and structural cardiac catheterization procedures, in a large prospective, randomized controlled trial. Up to 1,000 patient-c...
What is the current status of trial NCT06233578?
This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2024-01-10. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06233578?
The interventions under investigation include: RADPAD (DEVICE).
Who is sponsoring clinical trial NCT06233578?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06233578's enrollment target sits among peer trials
1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI